Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy ...

Diseases such as neovascular age-related macular degeneration (nAMD), myopic ... diagnosis and initiate the correct treatment, geographic atrophy (GA) must be differentiated from similar diseases.

The examination and diagnosis of geographic atrophy (GA) is done by combining ophthalmological and imaging techniques. The first step in diagnosing age-related macular degeneration (AMD ...

ARVO meeting will be held in Salt Lake City, Utah and feature presentation on clinical trials from around the globe.

Geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), leads to significant progressive vision loss and blindness. With a rise in the aging population around the ...

For over 5 million people worldwide diagnosed with Geographic Atrophy (GA)[i], an advanced form of age-related macular degeneration (AMD), the world is slowly fading to grey as central vision loss ...

Eyecyte-RPE™, in patients with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). All patients across three cohorts were dosed without any serious adverse events.

A novel DIPN method enhances GA segmentation by integrating ConvLSTM, projection attention, adaptive pooling, and contrastive ...

Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic ... secondary to age-related macular degeneration (AMD), a leading ...

Astellas has suffered another major setback with geographic atrophy (GA ... in the US since 2023 for GA secondary to age-related macular degeneration (AMD), a leading cause of blindness, given ...